CervoMed Inc. SEC filings CRVO
CervoMed Inc. has 1,000 filings in SEC EDGAR's recent list, going back to Oct 15, 1998. Its latest annual report, Form ARS, was filed on Apr 30, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 7, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Oct 29, 2026 (regulation fd disclosure, other events). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| DEF 14A | Proxy statement | Apr 30, 2026 | Jun 8, 2026 |
| DEF 14A | Proxy statement | Apr 29, 2025 | Jun 23, 2025 |
| DEF 14A | Proxy statement | Apr 29, 2024 | Jun 14, 2024 |
| DEFA14A | Additional proxy material | Dec 16, 2022 | — |
| DEFA14A | Additional proxy material | Dec 6, 2022 | — |
| DEFA14A | Additional proxy material | Dec 1, 2022 | — |
| DEFA14A | Additional proxy material | Nov 14, 2022 | — |
| DEFA14A | Additional proxy material | Apr 8, 2022 | — |
| DEFA14A | Additional proxy material | Mar 30, 2022 | — |
| DEF 14A | Proxy statement | Mar 28, 2022 | Apr 14, 2022 |
| PRE 14A | Preliminary proxy statement | Mar 18, 2022 | Apr 14, 2022 |
| DEF 14A | Proxy statement | Feb 28, 2022 | Apr 14, 2022 |
| PRE 14A | Preliminary proxy statement | Feb 18, 2022 | Apr 14, 2022 |
| DEFA14A | Additional proxy material | Jun 21, 2021 | — |
| DEFA14A | Additional proxy material | May 20, 2021 | — |
| DEF 14A | Proxy statement | Apr 30, 2021 | Jun 25, 2021 |
| DEFA14A | Additional proxy material | Apr 29, 2020 | — |
| DEF 14A | Proxy statement | Apr 29, 2020 | Jun 17, 2020 |
| PRE 14A | Preliminary proxy statement | Apr 17, 2020 | Jun 17, 2020 |
| DEFA14A | Additional proxy material | Apr 30, 2019 | — |
| DEF 14A | Proxy statement | Apr 30, 2019 | Jun 13, 2019 |
| DEFA14A | Additional proxy material | Apr 30, 2018 | — |
| DEF 14A | Proxy statement | Apr 30, 2018 | Jun 14, 2018 |
| PRE 14A | Preliminary proxy statement | Apr 20, 2018 | Jun 14, 2018 |
| DEF 14A | Proxy statement | Sep 18, 2017 | Nov 1, 2017 |
| PRE 14A | Preliminary proxy statement | Sep 8, 2017 | Nov 1, 2017 |
| DEF 14A | Proxy statement | May 12, 2017 | Jun 15, 2017 |
| PRE 14A | Preliminary proxy statement | May 1, 2017 | Jun 15, 2017 |
| DEF 14A | Proxy statement | Dec 8, 2016 | Jan 6, 2017 |
| PRE 14A | Preliminary proxy statement | Nov 28, 2016 | Jan 6, 2017 |
| DEFA14A | Additional proxy material | Jun 10, 2016 | — |
| DEF 14A | Proxy statement | Jun 10, 2016 | Jul 21, 2016 |
| PRE 14A | Preliminary proxy statement | May 27, 2016 | Jul 21, 2016 |
| DEFA14A | Additional proxy material | Apr 24, 2015 | — |
| DEF 14A | Proxy statement | Apr 24, 2015 | Jun 17, 2015 |
| PRE 14A | Preliminary proxy statement | Apr 3, 2015 | Jun 17, 2015 |
| DEF 14C | Information statement | Feb 12, 2014 | Mar 5, 2014 |
| PRE 14C | Preliminary information statement | Jan 17, 2014 | Jan 31, 2014 |
| PRE 14C | Filing | Oct 31, 2013 | Oct 30, 2013 |
| DEF 14C | Information statement | Jul 10, 2013 | Jul 8, 2013 |
| PRE 14C | Filing | Jun 26, 2013 | Jun 30, 2013 |
| DEF 14C | Information statement | Oct 2, 2012 | Oct 25, 2012 |
| PRE 14C | Preliminary information statement | Sep 12, 2012 | Sep 30, 2012 |
| DEF 14C | Information statement | May 8, 2008 | May 8, 2008 |
| PRE 14C | Filing | Apr 17, 2008 | Apr 17, 2008 |
| DEF 14A | Proxy statement | Jun 23, 2000 | Jul 26, 2000 |
| PRE 14A | Preliminary proxy statement | Jun 9, 2000 | Jul 26, 2000 |
| DEF 14A | Proxy statement | Apr 12, 1999 | Mar 31, 1999 |
Showing 48 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- CRVO (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Boston, MA
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 1053691
- Former names
- Diffusion Pharmaceuticals Inc. (until Aug 14, 2023); RestorGenex Corp (until Jan 14, 2016); Stratus Media Group, Inc (until Mar 7, 2014); FERIS INTERNATIONAL, INC. (until Jul 16, 2008); TITAN MOTORCYCLE CO OF AMERICA INC (until Feb 22, 2008)
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.